How big is the Sweden Pharmaceutical Market?

The Sweden Pharmaceutical Market size is expected to reach USD 5.60 billion in 2024 and grow at a CAGR of 5.49% to reach USD 7.31 billion by 2029. Read More

What is the current Sweden Pharmaceutical Market size?

In 2024, the Sweden Pharmaceutical Market size is expected to reach USD 5.60 billion. Read More

Who are the key players in Sweden Pharmaceutical Market?

Amgen Inc., Pfizer Inc., Orifarm Group A/S, Merck & Co., Inc. and Novartis AG are the major companies operating in the Sweden Pharmaceutical Market. Read More

What years does this Sweden Pharmaceutical Market cover, and what was the market size in 2023?

In 2023, the Sweden Pharmaceutical Market size was estimated at USD 5.29 billion. The report covers the Sweden Pharmaceutical Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Sweden Pharmaceutical Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Sweden Pharmaceutical Market Share

Statistics for the 2023 & 2024 Sweden Pharmaceutical market share, created by Mordor Intelligence™ Industry Reports. Sweden Pharmaceutical share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Sweden Pharmaceutical Industry

The Sweden pharmaceutical market is highly competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions in the country. Some of the key companies that are currently dominating the market are Merck & Co., Inc., Novartis AG, Amgen Inc., Pfizer Inc., and Orifarm Group A/S.